Exploristics signs collaboration agreement with Renovion, using the cloud-based simulation platform KerusCloud for smarter clinical study design
Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innovative study simulation software platform KerusCloud to e
Exploristics wins Innovate UK award
Innovate UK grants Smart Award to expand KerusCloud.
Susan Clement-Davies joins the Exploristics Board as a Non-Executive Director
Exploristics is delighted to welcome Susan Clement-Davies to the Board as a Non-Executive Director. Susan is an experienced life sciences financier
Exploristics CEO, Aiden Flynn, appointed Commercial Director at PSI
We are delighted to announce that Exploristics’ CEO, Dr Aiden Flynn, has been appointed Commercial Director on the Board of Directors at PSI.
Exploristics signs collaboration agreement with Istesso
Exploristics is pleased to announce a new collaboration agreement with Istesso to embed study simulation using innovative software platform KerusCloud.
KerusCloud Spring 2021 Release
We are pleased to announce the global launch of the KerusCloud Spring 2021 release, Exploristics’ ground-breaking clinical trial design platform.
Exploristics Joins the Wise Campaign
Exploristics have joined the WISE Campaign, and are delighted to be part of the journey promoting STEM, equality, diversity and inclusion.
Exploristics signs collaboration agreement with Galapagos
Exploristics signs collaboration agreement with Galapagos to embed study simulation into clinical development with innovative software platform KerusCloud.
Exploristics awarded membership of the NIWISE Hub
We’re delighted to have been awarded membership of the NIWISE hub.
Exploristics Joins UKRI Strength in Places
Exploristics joins the Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT).
Platinum Level Innovator
Exploristics has been recognised as a Platinum Level Innovator by Innovate NI.
People Always, Patients Sometimes
Exploristics’ CEO discusses how data simulation studies can reduce the risk and costs of clinical trials.
Collaboration with the Francis Crick Institute and UCL on the COVASE trial
Exploristics is pleased to announce its involvement with the COVASE trial evaluating cystic fibrosis drug, Dornase alfa, as a treatment for COVID-19.
Exploristics joins the UK BioIndustry Association
Exploristics is pleased to have become a member of the UK BioIndustry Association.
Introductory webinars on KerusCloud 2
We are hosting an initial series of webinars following the global launch of KerusCloud 2.
KerusCloud2 platform launches 29/04/2020
We are pleased to announce the global launch of the next generation of the ground-breaking KerusCloud 2.
Exploristics gain Bronze Diversity Charter Mark
Exploristics receives Bronze Diversity Charter Mark
Exploristics joins the Avicenna Alliance
Exploristics is pleased announce that we have joined the Avicenna Alliance.
Innovate UK Awards Exploristics £340K to extend KerusCloud
Exploristics has won a prestigious Innovate UK Smart award for £340K.
Exploristics nominated for Industry Award
Exploristics nominated for the Innovation of the Year award at the Irish Pharma Industry Awards 2019.
Diversity Mark Bronze Charter Mark
Exploristics has been awarded the Bronze Diversity Mark Charter Mark.
Help Exploristics celebrate ten years in business
Exploristics is celebrating its ten year anniversary!
New £1m investment & a new non-exec chairman
Two new announcements this week from Exploristics.
Exploristics signs collaboration agreement with Renovion, using the cloud-based simulation platform KerusCloud for smarter clinical study design
Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innova
Exploristics wins Innovate UK award
Innovate UK grants Smart Award to expand KerusCloud.
Susan Clement-Davies joins the Exploristics Board as a Non-Executive Director
Exploristics is delighted to welcome Susan Clement-Davies to the Board as a Non-Executive Director.
Exploristics CEO, Aiden Flynn, appointed Commercial Director at PSI
We are delighted to announce that Exploristics’ CEO, Dr Aiden Flynn, has been appointed Commercial
Exploristics signs collaboration agreement with Istesso
Exploristics is pleased to announce a new collaboration agreement with Istesso to embed study simula
KerusCloud Spring 2021 Release
We are pleased to announce the global launch of the KerusCloud Spring 2021 release, Exploristics’
Exploristics Joins the Wise Campaign
Exploristics have joined the WISE Campaign, and are delighted to be part of the journey promoting ST
Exploristics signs collaboration agreement with Galapagos
Exploristics signs collaboration agreement with Galapagos to embed study simulation into clinical de
Exploristics awarded membership of the NIWISE Hub
We’re delighted to have been awarded membership of the NIWISE hub.
Exploristics Joins UKRI Strength in Places
Exploristics joins the Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT).
Platinum Level Innovator
Exploristics has been recognised as a Platinum Level Innovator by Innovate NI.
People Always, Patients Sometimes
Exploristics’ CEO discusses how data simulation studies can reduce the risk and costs of clinical
Collaboration with the Francis Crick Institute and UCL on the COVASE trial
Exploristics is pleased to announce its involvement with the COVASE trial evaluating cystic fibrosis
Exploristics joins the UK BioIndustry Association
Exploristics is pleased to have become a member of the UK BioIndustry Association.
Introductory webinars on KerusCloud 2
We are hosting an initial series of webinars following the global launch of KerusCloud 2.
KerusCloud2 platform launches 29/04/2020
We are pleased to announce the global launch of the next generation of the ground-breaking KerusClou
Exploristics gain Bronze Diversity Charter Mark
Exploristics receives Bronze Diversity Charter Mark
Exploristics joins the Avicenna Alliance
Exploristics is pleased announce that we have joined the Avicenna Alliance.
Innovate UK Awards Exploristics £340K to extend KerusCloud
Exploristics has won a prestigious Innovate UK Smart award for £340K.
Exploristics nominated for Industry Award
Exploristics nominated for the Innovation of the Year award at the Irish Pharma Industry Awards 2019
Diversity Mark Bronze Charter Mark
Exploristics has been awarded the Bronze Diversity Mark Charter Mark.
Help Exploristics celebrate ten years in business
Exploristics is celebrating its ten year anniversary!
New £1m investment & a new non-exec chairman
Two new announcements this week from Exploristics.